跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,439 条关于
“WuXi AppTec Co. Ltd.”
全部
18,439
临床试验
4,421
药物
1,817
机构
4,356
资讯
7,845
去年
US Small Molecule API CDMO Market Projected to Reach $12.49 Billion by 2030 Driven by FDA Approvals and HPAPI Demand
去年
WuXi AppTec Predicts Shift from Antibodies to Peptides in Radiopharmaceutical Development
3个月前
WuXi AppTec Added to Pentagon's Chinese Military Companies List, Raising Supply Chain Concerns for US Pharma
10个月前
NEOM and WuXi AppTec Sign Strategic Partnership to Establish Pharmaceutical Manufacturing Hub in Saudi Arabia
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
17年前
WuXi PharmaTech Strengthens Board with Strategic Appointments of Industry Veterans
第 1 页,共 785 页
上一页
下一页